newsfilter
← Latest News
PR Newswire·

IM Cannabis Corp. Announces Third Quarter 2026 Financial Results

  • IM Cannabis Corp. reported Q3 2026 revenue of C$1.65 million, a decline from C$5.08 million in the same period of 2025.
  • The company recorded a Q3 2026 net loss of C$7.08 million, compared to a net loss of C$3.87 million in Q3 2025.
  • For the first nine months of 2026, revenue totaled C$8.96 million, down from C$15.77 million in the corresponding 2025 period, with a net loss of C$13.93 million.
  • In September 2026, IM Cannabis announced a non-binding agreement to acquire a 51% stake in Polish unmanned aerial systems firm Space Defense Innovations LLC (SDI).
  • The company completed the sale of its European operations, including German subsidiary Adjupharm GmbH, to Slil.com Holding Ltd. on September 29, 2026.
  • The European sale transaction included a C$3 million advance payment & the assumption of liabilities up to C$9.4 million.
  • IM Cannabis expects the European divestiture to improve shareholders' equity by approximately C$3 million while retaining its Israeli medical cannabis operations.
Company
IM Cannabis Corp.
Keywords
IM Cannabis Corp.